Ernexa Therapeutics, Inc. engages in the research and development of cellular therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. Its pipeline includes ERNA-101 (Ovarian Cancer) and ERNA-201 (Rheumatoid Arthritis). The company was founded in 1984 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
52 week high is the highest price of a stock in the past 52 weeks, or one year. Ernexa Therapeutics Inc. - Warrants (04/02/2030) 52 week high is $0.2278 as of November 14, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Ernexa Therapeutics Inc. - Warrants (04/02/2030) 52 week low is $0.0211 as of November 14, 2026.
Ernexa Therapeutics Inc. - Warrants (04/02/2030) stock price today is $0.0258.
Ernexa Therapeutics Inc. - Warrants (04/02/2030) stock price yesterday was $0.0257.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Ernexa Therapeutics Inc. - Warrants (04/02/2030) 50-day moving average is $0.0306.